Clinical Trial Update: The Clinical Study of Apatinib Plus S1 for Patients With Advanced Non-squamous Head and Neck Cancer [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 clinical study evaluating the combination of apatinib and S-1 in patients with advanced non-squamous head and neck…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Apatinib (apatinib)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Head and Neck Neoplasms | Phase 2 | Status: UNKNOWN